Healthcare of Ontario Pension Plan Trust Fund Acquires Shares of 31,217 Eastman Chemical (NYSE:EMN)

Healthcare of Ontario Pension Plan Trust Fund acquired a new stake in shares of Eastman Chemical (NYSE:EMNFree Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm acquired 31,217 shares of the basic materials company’s stock, valued at approximately $2,804,000.

A number of other institutional investors have also added to or reduced their stakes in the stock. Vanguard Group Inc. grew its holdings in Eastman Chemical by 0.4% during the 4th quarter. Vanguard Group Inc. now owns 14,839,723 shares of the basic materials company’s stock valued at $1,332,904,000 after buying an additional 61,580 shares in the last quarter. Putnam Investments LLC boosted its position in shares of Eastman Chemical by 4.0% during the 4th quarter. Putnam Investments LLC now owns 4,355,408 shares of the basic materials company’s stock valued at $391,203,000 after acquiring an additional 168,038 shares during the last quarter. Morgan Stanley boosted its position in shares of Eastman Chemical by 1.0% during the 3rd quarter. Morgan Stanley now owns 3,978,856 shares of the basic materials company’s stock valued at $305,258,000 after acquiring an additional 39,860 shares during the last quarter. Invesco Ltd. boosted its position in shares of Eastman Chemical by 37.4% during the 3rd quarter. Invesco Ltd. now owns 2,795,824 shares of the basic materials company’s stock valued at $214,496,000 after acquiring an additional 760,974 shares during the last quarter. Finally, Massachusetts Financial Services Co. MA boosted its position in shares of Eastman Chemical by 7.0% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 2,575,783 shares of the basic materials company’s stock valued at $231,357,000 after acquiring an additional 168,009 shares during the last quarter. 83.65% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other news, CEO Mark J. Costa sold 102,390 shares of the firm’s stock in a transaction on Tuesday, May 7th. The stock was sold at an average price of $100.78, for a total transaction of $10,318,864.20. Following the transaction, the chief executive officer now owns 395,699 shares in the company, valued at $39,878,545.22. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. In other Eastman Chemical news, SVP Adrian James Holt sold 3,662 shares of Eastman Chemical stock in a transaction dated Friday, May 10th. The stock was sold at an average price of $101.26, for a total value of $370,814.12. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Mark J. Costa sold 102,390 shares of Eastman Chemical stock in a transaction dated Tuesday, May 7th. The shares were sold at an average price of $100.78, for a total value of $10,318,864.20. Following the completion of the transaction, the chief executive officer now owns 395,699 shares in the company, valued at approximately $39,878,545.22. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 108,027 shares of company stock worth $10,885,638. Company insiders own 2.28% of the company’s stock.

Eastman Chemical Stock Down 0.2 %

NYSE:EMN opened at $99.28 on Tuesday. Eastman Chemical has a twelve month low of $68.89 and a twelve month high of $105.98. The company has a market cap of $11.68 billion, a price-to-earnings ratio of 12.79, a price-to-earnings-growth ratio of 1.08 and a beta of 1.51. The stock has a fifty day simple moving average of $99.23 and a 200-day simple moving average of $92.45. The company has a current ratio of 1.39, a quick ratio of 0.71 and a debt-to-equity ratio of 0.77.

Eastman Chemical (NYSE:EMNGet Free Report) last released its earnings results on Thursday, April 25th. The basic materials company reported $1.61 earnings per share for the quarter, topping the consensus estimate of $1.41 by $0.20. Eastman Chemical had a return on equity of 13.84% and a net margin of 10.16%. The business had revenue of $2.31 billion during the quarter, compared to the consensus estimate of $2.29 billion. During the same period last year, the company earned $1.63 earnings per share. The business’s revenue for the quarter was down 4.2% compared to the same quarter last year. Analysts anticipate that Eastman Chemical will post 7.75 EPS for the current year.

Eastman Chemical Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, July 9th. Stockholders of record on Monday, June 17th will be paid a dividend of $0.81 per share. The ex-dividend date of this dividend is Monday, June 17th. This represents a $3.24 annualized dividend and a dividend yield of 3.26%. Eastman Chemical’s dividend payout ratio is currently 41.75%.

Analysts Set New Price Targets

A number of research firms have recently commented on EMN. Wells Fargo & Company increased their target price on Eastman Chemical from $89.00 to $100.00 and gave the company an “equal weight” rating in a research report on Thursday, April 11th. KeyCorp increased their target price on Eastman Chemical from $101.00 to $121.00 and gave the company an “overweight” rating in a research report on Tuesday, April 9th. Jefferies Financial Group upgraded Eastman Chemical from a “hold” rating to a “buy” rating and increased their target price for the company from $102.00 to $125.00 in a research report on Monday, April 29th. StockNews.com upgraded Eastman Chemical from a “hold” rating to a “buy” rating in a research report on Monday, May 13th. Finally, Bank of America lowered their price target on Eastman Chemical from $113.00 to $112.00 and set a “buy” rating for the company in a research report on Monday, April 29th. Six investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. Based on data from MarketBeat, Eastman Chemical presently has an average rating of “Moderate Buy” and a consensus target price of $107.50.

Read Our Latest Report on EMN

Eastman Chemical Company Profile

(Free Report)

Eastman Chemical Company operates as a specialty materials company in the United States, China, and internationally. The company's Additives & Functional Products segment offers amine derivative-based building blocks, intermediates for surfactants, metam-based soil fumigants, and organic acid-based solutions; specialty coalescent and solvents, paint additives, and specialty polymers; and heat transfer and aviation fluids.

Featured Stories

Want to see what other hedge funds are holding EMN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Eastman Chemical (NYSE:EMNFree Report).

Institutional Ownership by Quarter for Eastman Chemical (NYSE:EMN)

Receive News & Ratings for Eastman Chemical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eastman Chemical and related companies with MarketBeat.com's FREE daily email newsletter.